Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1891 1
1894 2
1895 3
1896 2
1897 1
1910 1
1922 1
1925 1
1931 1
1943 2
1947 1
1948 2
1949 1
1951 1
1952 1
1953 5
1954 1
1956 1
1957 1
1960 1
1961 1
1963 1
1969 1
1971 3
1973 2
1974 1
1975 4
1976 7
1977 1
1978 1
1979 4
1980 8
1981 3
1982 5
1983 5
1984 11
1985 5
1986 3
1988 6
1989 2
1990 9
1991 4
1992 9
1993 10
1994 13
1995 22
1996 35
1997 38
1998 31
1999 42
2000 53
2001 53
2002 63
2003 70
2004 68
2005 78
2006 71
2007 100
2008 103
2009 100
2010 127
2011 162
2012 197
2013 250
2014 235
2015 236
2016 200
2017 174
2018 147
2019 137
2020 142
2021 149
2022 119
2023 52
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22369348

3,012 results

Results by year

Filters applied: . Clear all
Page 1
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
Kijima T, Fujii Y, Yokoyama M, Ishioka J, Matsuoka Y, Numao N, Saito K, Koga F, Masuda H, Kawakami S, Kihara K. Kijima T, et al. BJU Int. 2012 Oct;110(8):1149-55. doi: 10.1111/j.1464-410X.2012.10959.x. Epub 2012 Feb 28. BJU Int. 2012. PMID: 22369348
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H, Okihara K, Miyake H, Fujisawa M, Miyoshi S, Matsumoto T, Fujii M, Takihana Y, Usui T, Matsuda T, Ozono S, Kumon H, Ichikawa T, Miki T; Nonsteroidal Antiandrogen Sequential Alternation for Prostate Cancer Study Group. Suzuki H, et al. J Urol. 2008 Sep;180(3):921-7. doi: 10.1016/j.juro.2008.05.045. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635218
3,012 results